A study finds that, contrary to some reports, the use of inhaled nitric oxide can be effective in treating premature…
Articles by Ashraf Malhas, PhD
Supplemental oxygen use is associated with improved survival in a subpopulation of patients with pulmonary arterial hypertension (PAH), a…
The healthcare costs of Americans with pulmonary arterial hypertension (PAH) are about the same before and after treatment starts, mainly because…
A generic molecule that works by activating a mitochrondrial protein, dichloroacetate (DCA), was seen in a Phase 1 clinical trial to…
Pulmonary artery dilation speeds up the progression of pediatric idiopathic and heritable pulmonary arterial hypertension (PAH), a Japanese study shows. Dilation of…
Pulmonary arterial hypertension (PAH) is a rare complication of systemic lupus erythematosus (SLE)Â and is associated with the presence of specific…
The U.S. Food and Drug Administration (FDA) has declined SteadyMed Therapeutics‘ new drug application (NDA) for its Trevyent (treprostinil injection) therapy to…